Results 261 to 270 of about 73,620 (322)

Extracellular vesicles in multiple myeloma: pathogenesis and therapeutic application

open access: yesThe FEBS Journal, EarlyView.
Multiple myeloma is characterised by the clonal proliferation of plasma cells in the bone marrow. Extracellular vesicles (EVs) are a key component of cell‐to‐cell communication within the bone marrow microenvironment, promoting tumour growth, bone remodelling, immune modulation, angiogenesis and therapeutic resistance.
Chloe Wylie   +3 more
wiley   +1 more source

Prognostic impact of next-generation sequencing on myelodysplastic syndrome: A single-center experience. [PDF]

open access: yesMedicine (Baltimore)
Bülbül H   +5 more
europepmc   +1 more source

Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy. [PDF]

open access: yesBlood Adv
Jen WY   +17 more
europepmc   +1 more source

Liquid Biopsy for Enhanced Specificity in Identifying Somatic Mutations in Aggressive Non‐Hodgkin Large B‐Cell Lymphoma: A Comparative Study of Cell‐Free DNA and Formalin‐Fixed Paraffin‐Embedded Tissue

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Formalin‐fixed paraffin‐embedded (FFPE) tumor biopsy is the current mainstay of genotyping, but is limited by its invasiveness and tumor heterogeneity. Plasma cell‐free DNA (cfDNA) constitutes a minimally invasive alternative that may better capture tumor‐derived profiles from circulating tumor DNA (ctDNA). This study compares the
Gayaththri Vimalathas   +7 more
wiley   +1 more source

Transplant in myeloma: who, when, and why? [PDF]

open access: yesHematology Am Soc Hematol Educ Program
Perrot A.
europepmc   +1 more source

Next Generation Sequencing Identifies Subgroups of Patients With Triple Negative Primary Thrombocytosis With Different Clinical Thrombotic Outcomes

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The majority of patients with essential thrombocythemia (ET) show somatic mutations of JAK2, CALR, or MPL. Around 10% of cases lack these mutations (“triple negative” ET, TN‐ET). Additionally, some patients with bona fide “primary thrombocytosis” (PT) [i.e., high platelet (PLT)‐ count with no apparent underlying causes] do not ...
Valentina Sangiorgio   +8 more
wiley   +1 more source

Diagnosis of myelodysplastic syndromes: the classic and the novel. [PDF]

open access: yesHaematologica
Oster HS   +2 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy